MedPath

A clinical trial to study the effect of changes in the strength of pulse to predict the onset of caudal block which is a method of giving pain relief in children

Not yet recruiting
Conditions
Encysted hydrocele, (2) ICD-10 Condition: N433||Hydrocele, unspecified, (3) ICD-10 Condition: O||Medical and Surgical, (4) ICD-10 Condition: N471||Phimosis, (5) ICD-10 Condition: N472||Paraphimosis,
Registration Number
CTRI/2021/06/034021
Lead Sponsor
Institute of Anaesthesiology and Critical care
Brief Summary

This study is a randomised controlled single blinded clinical trial to evaluate the effectiveness of Perfusion Index as a predictor of successful caudal block in children under 5 years.Perfusion index is measured at baseline and after caudal block in one group and without caudal block in another group.More than 100% Increase in perfusion index will be considered as onset of successful caudal block

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Children under 5 years Elective infraumbilical surgeries ASA PS I.

Exclusion Criteria

Parents refusal Allergic to drug Severe cardiovascular, respiratory,renal, neurological, hepatic disease Local infection Bleeding diathesis.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To monitor perfusion index after caudal block at regular time intervals at T0,T3,T5,T10,T15,T20,T30Baseline,3min,5min,10min,15min,20min,30min and hourly till 6 hours in the recovery room
Secondary Outcome Measures
NameTimeMethod
Patient Hemodynamic parametersPerioperative period

Trial Locations

Locations (1)

Institute of Child health and hospital for children

🇮🇳

Chennai, TAMIL NADU, India

Institute of Child health and hospital for children
🇮🇳Chennai, TAMIL NADU, India
N KRISHNAN
Principal investigator
9444451194
krishpaedanaes@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.